BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3068674)

  • 1. The development of fluorescence immunoassays.
    Barnard G
    Prog Clin Biol Res; 1988; 285():15-37. PubMed ID: 3068674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High specific activity chemiluminescent and fluorescent markers: their potential application to high sensitivity and 'multi-analyte' immunoassays.
    Ekins R; Chu F; Micallef J
    J Biolumin Chemilumin; 1989 Jul; 4(1):59-78. PubMed ID: 2801243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-resolved fluorescence in biospecific assays.
    Soini E; Hemmilä I; Dahlén P
    Ann Biol Clin (Paris); 1990; 48(8):567-71. PubMed ID: 2288444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol-reactive, luminescent Europium chelates: luminescence probes for resonance energy transfer distance measurements in biomolecules.
    Heyduk E; Heyduk T
    Anal Biochem; 1997 Jun; 248(2):216-27. PubMed ID: 9177747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How alternative are immunoassay systems employing non-radioisotopic labels? A comparative appraisal of their main analytical characteristics.
    Pelizzola D; Bombardieri E; Brocchi A; Cappelli G; Coli A; Federghini M; Giganti M; Gion M; Madeddu G; Maussieri ML
    Q J Nucl Med; 1995 Dec; 39(4):251-63. PubMed ID: 8624786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence polarization competition immunoassay for tyrosine kinases.
    Seethala R
    Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selected history and future of immunoassay development and applications in clinical chemistry.
    Wu AH
    Clin Chim Acta; 2006 Jul; 369(2):119-24. PubMed ID: 16701599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody.
    Turek TC; Small EC; Bryant RW; Hill WA
    Anal Biochem; 2001 Dec; 299(1):45-53. PubMed ID: 11726183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microchip-based homogeneous immunoassay using fluorescence polarization spectroscopy.
    Tachi T; Kaji N; Tokeshi M; Baba Y
    Lab Chip; 2009 Apr; 9(7):966-71. PubMed ID: 19294309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Time-resolved fluorometry: principles and applications in clinical biology].
    Gaillard O; Kapel N; Galli J; Delattre J; Meillet D
    Ann Biol Clin (Paris); 1994; 52(11):751-5. PubMed ID: 7747882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroimmunoassays and immunofluorometric assays.
    Hemmilä I
    Clin Chem; 1985 Mar; 31(3):359-70. PubMed ID: 3882272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct monitoring of molecular recognition processes using fluorescence enhancement at colloid-coated microplates.
    Lobmaier C; Hawa G; Götzinger M; Wirth M; Pittner F; Gabor F
    J Mol Recognit; 2001; 14(4):215-22. PubMed ID: 11500967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New trends in immunoassays.
    Chan CP; Cheung YC; Renneberg R; Seydack M
    Adv Biochem Eng Biotechnol; 2008; 109():123-54. PubMed ID: 17874052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Competitive immunoassay and immunometric immunoassay].
    Miyachi Y
    Nihon Rinsho; 1995 Sep; 53(9):2112-8. PubMed ID: 7474367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201.
    Buchli R; Vangundy RS; Giberson CF; Hildebrand WH
    J Immunol Methods; 2006 Jul; 314(1-2):38-53. PubMed ID: 16844138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid detection using non-radioactive labelling methods.
    Mansfield ES; Worley JM; McKenzie SE; Surrey S; Rappaport E; Fortina P
    Mol Cell Probes; 1995 Jun; 9(3):145-56. PubMed ID: 7477006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple labeling of antibodies with dye/DNA conjugate for sensitivity improvement in fluorescence immunoassay.
    Zhang Q; Guo LH
    Bioconjug Chem; 2007; 18(5):1668-72. PubMed ID: 17685565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAMAM structure-based multifunctional fluorescent conjugates for improved fluorescent labelling of biomacromolecules.
    Wängler C; Moldenhauer G; Saffrich R; Knapp EM; Beijer B; Schnölzer M; Wängler B; Eisenhut M; Haberkorn U; Mier W
    Chemistry; 2008; 14(27):8116-30. PubMed ID: 18752247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycerin suppression of fluorescence self-quenching and improvement of heterogeneous fluoroimmunoassay sensitivity.
    Petrou PS; Mastichiadis C; Christofidis I; Kakabakos SE
    Anal Chem; 2007 Jan; 79(2):647-53. PubMed ID: 17222032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.